FTXH icon

First Trust Nasdaq Pharmaceuticals ETF
FTXH

Overview Fund Activity

22 hedge funds and large institutions have $7.55M invested in First Trust Nasdaq Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.

Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NA
1
NewEdge Advisors
Louisiana
$616K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$1.25M
3
Envestnet Asset Management
3
Envestnet Asset Management
Illinois
$404K
4
Morgan Stanley
4
Morgan Stanley
New York
$171K
5
NB
5
NBT Bank
New York
$44.4K

Top Sellers

1
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$185K
2
Goldman Sachs
2
Goldman Sachs
New York
$1.38M
3
OMC
3
Old Mission Capital
Illinois
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
SPIA
5
Steward Partners Investment Advisory
New York
$238K
Name Holding Trade Value Shares
Change 		Shares
Change %
SWP
26
Stratos Wealth Partners
Ohio
– -$228K -8,361 Closed
IAIM
27
International Assets Investment Management
Florida
– -$72.5K -2,662 Closed
UBS Group
28
UBS Group
Switzerland
– -$790 -29 Closed
1
2